drugset / Trial / NCT07703904
To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluation of the pharmacokinetics of Hemay 5259 sustained-release tablets in healthy human subjects
Timeline
- Start
- 2026-07-01
- Primary completion
- 2026-08-31
- Completion
- 2026-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hemay5259 | Unknown | 120 mg | Oral |
| Subject | Hemay5259 | Unknown | 150 mg | Oral |
Indications
No indication recorded.